EMCUREEmcure Pharmaceuticals Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹1,861.20
▲ 4.37%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)33,823.80
P/E36.62
P/B6.83
PEG1.27
ROE %19.57
ROCE %21.20
Debt / Equity0.31
EPS48.70
Revenue Growth %16.70
Profit Growth %28.80
Dividend Yield %0.17
Promoter Holding %81.70
FII Holding %5.45
DII Holding %—
Beta-0.02
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 62% | ₹1,861.20 | ₹1,751.00 | ₹2,054.20 | 1.75 |
BUYConviction 85%
Why buy
- • Revenue growth: 16.7% YoY
- • Profit growth: 28.8% YoY
- • ROE: 19.6%
- • RSI: 60
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 62%)
Bull case
- • Revenue growth: 16.7% YoY
- • Profit growth: 28.8% YoY
- • ROE: 19.6%
- • RSI: 60
Bear case
- • Dividend yield: 0.17%
- • MACD: bearish
- • Trend strength (ADX): 18
- • Volume trend: 0.6x baseline
Key risks
- • Dividend yield: 0.17%
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹1,861.20
Stop Loss
₹1,733.49
risk 6.9%
Target 1 (1.5R)
₹2,052.76
+10.3%
Target 2 (3R)
₹2,244.33
+20.6%
Support (20d)
₹1,751.00
Resistance (52w)
₹1,944.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹127.71/share
ATR (volatility)
₹54.48
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹54.48). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
85
Technical
68
Momentum
78
Risk (safety)
70